Literature DB >> 11873080

Prevalence trend and correlates of HHV-8 infection in HIV-infected patients.

Saverio Giuseppe Parisi1, Loredana Sarmati, Marilena Pappagallo, Romualdo Mazzi, Giada Carolo, Francesca Farchi, Emanuele Nicastri, Ercole Concia, Giovanni Rezza, Massimo Andreoni.   

Abstract

To assess the circulation of human herpesvirus (HHV)-8 infection over the years, two seroprevalence surveys were conducted, which tested sera from HIV-infected individuals recruited 10 years apart (206 individuals from 1986 to 1988 and 177 individuals from 1997 to 1998). For all patients, antibodies to hepatitis C virus (HCV), hepatitis B virus (HBV), and HHV-8 lytic and latent antigens were evaluated.HHV-8 seroprevalence was higher among individuals recruited in the 1990s (31.6% for anti-lytic, 8.5% for anti-latent antibodies) compared with similar findings in those seen in the late 1980s (14.6% and 3.4% for anti-lytic and anti-latent antibodies, respectively), with a twofold increase of the risk of HHV-8 infection. However, the increase was observed only among injecting drug users, whereas seroprevalence tended to slightly increase among those infected by sexual contact. At univariate analysis, time of recruitment and being homosexual men were factors associated with HHV-8 infection, an association that remained after adjusting for age. HBV infection was significantly associated with HHV-8 infection (odds ratio [OR], 2.2; 95% confidence interval [CI], 1.3-3.6), whereas those infected with HCV had a lower probability of having HHV-8 antibodies (OR, 0.3; 95% CI, 0.20-0.6). After controlling for age and gender, time of recruitment remained independently associated with HHV-8 infection among injecting drug users. In conclusion, HHV-8 seroprevalence appears to be increased during 10 years among HIV-infected injection drug users but not among homosexual men, who remain those at the highest risk of infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11873080     DOI: 10.1097/00126334-200203010-00011

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  6 in total

Review 1.  Prevalence of Kaposi's sarcoma-associated herpesvirus among intravenous drug users: a systematic review and meta-analysis.

Authors:  Qiwen Fang; Zhenqiu Liu; Zhijie Zhang; Yan Zeng; Tiejun Zhang
Journal:  Virol Sin       Date:  2017-10-13       Impact factor: 4.327

2.  Use of a multiantigen detection algorithm for diagnosis of Kaposi's sarcoma-associated herpesvirus infection.

Authors:  A Scott Laney; Jonathan S Peters; Susan M Manzi; Lawrence A Kingsley; Yuan Chang; Patrick S Moore
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

3.  Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV.

Authors:  Nicola Schinaia; Yllka Kodra; Loredana Sarmati; Massimo Andreoni; Silva Bino; Shpetim Qyra; Giovanni Rezza
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

4.  Human herpesvirus 8 seroprevalence, China.

Authors:  Tiejun Zhang; Xiaodan Shao; Yue Chen; Tao Zhang; Veenu Minhas; Charles Wood; Na He
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

5.  Incidence of human herpesvirus 8 (HHV-8) infection among HIV-uninfected individuals at high risk for sexually transmitted infections.

Authors:  Massimo Giuliani; Paola Cordiali-Fei; Concetta Castilletti; Aldo Di Carlo; Guido Palamara; Stefano Boros; Giovanni Rezza
Journal:  BMC Infect Dis       Date:  2007-12-05       Impact factor: 3.090

Review 6.  HHV-8 seroprevalence: a global view.

Authors:  Eliane Rohner; Natascha Wyss; Sven Trelle; Sam M Mbulaiteye; Matthias Egger; Urban Novak; Marcel Zwahlen; Julia Bohlius
Journal:  Syst Rev       Date:  2014-02-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.